BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

983 related articles for article (PubMed ID: 25584736)

  • 1. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
    Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
    Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
    Lukovac S; Los EL; Stellaard F; Rings EH; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G520-31. PubMed ID: 19608735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR signaling in the enterohepatic system.
    Matsubara T; Li F; Gonzalez FJ
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):17-29. PubMed ID: 22609541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids: regulation of synthesis.
    Chiang JY
    J Lipid Res; 2009 Oct; 50(10):1955-66. PubMed ID: 19346330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of farnesoid X receptor and its role in bile acid metabolism.
    Chiang JYL; Ferrell JM
    Mol Cell Endocrinol; 2022 May; 548():111618. PubMed ID: 35283218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid Metabolism in Liver Pathobiology.
    Chiang JYL; Ferrell JM
    Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
    Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
    Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast β-glucan reduces obesity-associated
    So SY; Wu Q; Leung KS; Kundi ZM; Savidge TC; El-Nezami H
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G639-G655. PubMed ID: 34643089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
    Sonne DP; Hansen M; Knop FK
    Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.
    Browning MG; Pessoa BM; Khoraki J; Campos GM
    Curr Obes Rep; 2019 Jun; 8(2):175-184. PubMed ID: 30847736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
    Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
    Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Bile Acids in Metabolic Control.
    Molinaro A; Wahlström A; Marschall HU
    Trends Endocrinol Metab; 2018 Jan; 29(1):31-41. PubMed ID: 29195686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.